Expert Review Of Clinical Pharmacology

Journal Title：Expert Review Of Clinical Pharmacology

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.

Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

药物开发技术的进步正在催生创新的新疗法，从可能挽救生命的药物到生活方式产品。然而，近年来，开发新药的成本飙升，对耐药性和药物经济学的担忧也日益凸显。临床试验阶段的不良反应不断提醒人们严格的安全性和毒性测试的重要性。此外，药物基因组学和“个性化”治疗方法的出现将要求一种新的药物评估和医疗保健方法。

临床药理学在整合所有积极应对现代生物医学实践中此类挑战的专家和参与者的专业知识方面发挥着重要作用。

Expert Review Of Clinical Pharmacology创刊于2008年，由Taylor and Francis Ltd.出版商出版，收稿方向涵盖PHARMACOLOGY & PHARMACY全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 ，影响因子指数3.6，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。